{
  "content": "Crossref\nPubMed\nGoogle Scholar\n6.\nCamacho E.M., Lip G.Y.H. Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020-2040. Eur Heart J Qual Care Clin Outcomes. 2023;10:326-333.\nGoogle Scholar\n7.\nRingborg A., Nieuwlaat R., Lindgren P., et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10:403-411.\nGoogle Scholar\n8.\nWolowacz S.E., Samuel M., Brennan V.K., Jasso-Mosqueda J.G., Van Gelder I.C. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace. 2011;13:1375-1385.\nCrossref\nPubMed\nGoogle Scholar\n9.",
  "source": "https://www.jacc.org/doi/abs/10.1016/j.jacadv.2024.101117",
  "chunk_id": "dd650087-34e6-43a2-bee7-9df0f9c663c0",
  "similarity_score": 0.2660922408103943,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 27,
  "title": "Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations: Focus on antiarrhythmic drugs",
  "authors": "Danilo Menichelli, Pasquale Pignatelli, Tommaso Brogi, Arianna Pannunzio, Francesco Violi, Gregory Y.H. Lip, Daniele Pastori",
  "year": "2024",
  "journal": "JACC: Advances",
  "reference": "Menichelli, D., Pignatelli, P., Brogi, T., Pannunzio, A., Violi, F., Lip, G. Y. H., & Pastori, D. (2024). Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations: Focus on antiarrhythmic drugs. JACC: Advances, 3(8), 297-305. https://doi.org/10.1016/j.jaccadv.2024.07.015",
  "doi": "Not available",
  "chunk_index": 29,
  "total_chunks": 40,
  "retrieved_at": "2025-07-24T21:58:16.915832"
}